ND
Nishant Dilip Patel
About Nishant Dilip Patel
Data last updated:
Nishant Dilip Patel is a Designated Partner at Enviraxyme Llp (since 2025), Designated Partner at Quantumzyme Llp (since 2024) and Additional Director at Arete Life Sciences Private Limited (since 2017). The companies operate in Life Sciences and Business Services.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Enviraxyme Llp ACO-4639 | Designated Partner | 19 May 2025 | 2025 | Active | |
 Quantumzyme Llp AAH-4439 | Designated Partner | 30 Oct 2024 | 2016 | Active | |
| Arete Life Sciences Private Limited U74900KA2016PTC085062 | Additional Director | 21 Mar 2017 | 2016 | Active |
Board colleagues of Nishant Dilip Patel
| Name | DIN | Company | Designation |
|---|---|---|---|
| Nayan Arvind Dama | 11113650 | Enviraxyme Llp | Designated Partner |
| Naveen Kulkarni | 01317044 | Quantumzyme Llp | Designated Partner |
| Shilpa Ramdurg | 03024967 | Arete Life Sciences Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Nishant Dilip Patel
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nishant Dilip Patel
Nishant Dilip Patel currently holds 3 directorships: Enviraxyme Llp (Designated Partner, since 19 May 2025); Quantumzyme Llp (Designated Partner, since 30 Oct 2024); Arete Life Sciences Private Limited (Additional Director, since 21 Mar 2017).
Nishant Dilip Patel was first appointed on 21 Mar 2017 as Additional Director at Arete Life Sciences Private Limited. The most recent appointment on record is 19 May 2025 at Enviraxyme Llp.
The current boards of Nishant Dilip Patel's companies include Nayan Arvind Dama (Enviraxyme Llp), Naveen Kulkarni (Quantumzyme Llp), Shilpa Ramdurg (Arete Life Sciences Private Limited).